Stephen Davis, CEO at ACADIA PHARMACEUTICALS INC (ACAD), sold 103,126 shares at $21.96 ($2.3M) on 2023-10-06, disclosed to the SEC on 2023-10-06.
Seasonal sale ($2.3M) by CEO — this insider has traded ACAD in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.96 | 51,563 | $1.1M | 50.0% |
| 2 | $21.96 | 51,563 | $1.1M | 50.0% |
| Total | $21.96 avg | 103,126 | $2.3M | 100% |
| Filing → |
| ACAD | SELL | 2024-04-09 | $950K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $634K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $275K | — | Filing → |